US 8268851
Compositions and methods for inhibition of the JAK pathway
granted A61PA61P27/02A61P27/06
Quick answer
US patent 8268851 (Compositions and methods for inhibition of the JAK pathway) held by Rigel Pharmaceuticals, Inc. expires Mon Sep 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Rigel Pharmaceuticals, Inc.
- Grant date
- Tue Sep 18 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61P, A61P27/02, A61P27/06, A61P27/14, A61P37/06